bloodstream infections

Updated: July 11, 2024

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

taurolidine/citrate/heparin

Indicated for Catheter-related Bloodstream Infections:

In the process of obtaining FDA clearance for the avoidance of catheter-related bloodstream infections (CRBSIs) in individuals with end-stage renal disease (ESRD) undergoing hemodialysis via a central venous catheter

ticarcillin

3g IV dose every 4 hours for approximately 14 days or until the absolute neutrophil count becomes greater than 500cells/mm3

The dose can be increased as per symptoms and intensity of infection

cloxacillin

Oral Therapy:
Children under 20 kg: 25 to 50mg per kg per day divided equally at every 6 hours
Children equal or more than 20 kg: 250 to 500mg every 6 hours, dose modification depends on the severity of infection

Future Trends